Ironwood Pharmaceuticals, Inc.  

(Public, NASDAQ:IRWD)   Watch this stock  
Find more results for IRWD
13.39
+0.40 (3.08%)
Sep 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.74 - 13.47
52 week 8.95 - 15.95
Open 12.79
Vol / Avg. 0.00/1.06M
Mkt cap 1.81B
P/E     -
Div/yield     -
EPS -1.76
Shares 120.64M
Beta 1.52
Inst. own 108%
Oct 20, 2014
Q3 2014 Ironwood Pharmaceuticals Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 10, 2014
Ironwood Pharmaceuticals Inc at Morgan Stanley Healthcare Conference
Aug 4, 2014
Q2 2014 Ironwood Pharmaceuticals Inc Earnings Call - Webcast
Aug 4, 2014
Q2 2014 Ironwood Pharmaceuticals Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -882.41% -1192.31%
Operating margin -805.83% -1101.36%
EBITD margin - -1050.10%
Return on average assets -61.29% -107.22%
Return on average equity -146.38% -299.34%
Employees 534 -
CDP Score - -

Address

301 BINNEY STREET
CAMBRIDGE, MA 02142-1030
United States - Map
+1-617-6217722 (Phone)
+1-617-4940480 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

Officers and directors

Bryan E. Roberts Ph.D. Independent Chairman of the Board
Age: 47
Bio & Compensation  - Reuters
Peter M. Hecht Ph.D. Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Michael J. Higgins Chief Operating Officer
Age: 51
Bio & Compensation  - Reuters
Thomas Graney Chief Financial Officer, Senior Vice President - Finance, Corporate Strategy
Age: 49
Bio & Compensation  - Reuters
Mark G. Currie Ph.D. Senior Vice President, Chief Scientific Officer, President - Research and Development
Age: 59
Bio & Compensation  - Reuters
Thomas A. McCourt Senior Vice President - Marketing and Sales, Chief Commercial Officer
Age: 56
Bio & Compensation  - Reuters
Gina Consylman Chief Accounting Officer, Vice President, Corporate Controller
Age: 42
Bio & Compensation  - Reuters
Douglas E. Williams Ph.D. Director
Age: 56
Bio & Compensation  - Reuters
George H. Conrades Independent Director
Age: 75
Bio & Compensation  - Reuters
Joseph C. Cook Jr. Independent Director
Age: 72
Bio & Compensation  - Reuters